In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-628V (not to be published)
************************* CAMERON SHARP, * * * Chief Special Master Corcoran * Petitioner, * Filed: March 25, 2020 * v. * * Decision by Stipulation; Influenza Vaccine; SECRETARY OF HEALTH * Chronic Inflammatory Demyelinating AND HUMAN SERVICES, * Polyneuropathy. * Respondent. * * *************************
Amber D. Wilson, Maglio Christopher & Toale, P.A., Washington, D.C., for Petitioner.
Camille M. Collett, U.S. Dep’t of Justice, Washington, DC, for Respondent.
DECISION ON STIPULATION 1
On May 11, 2017, Cameron Sharp filed a petition seeking compensation under the National Vaccine Injury Compensation Program. 2 ECF No. 1. Petitioner alleged that he suffered from chronic inflammatory demyelinating polyneuropathy as a result of the influenza vaccine he received on December 7, 2015. Id. at 1. In October 2017, the parties began exploring informal resolution of the case. See Resp’s Status Rep. at 1, filed Oct. 7, 2017 (ECF No. 15). Eventually the parties were able to agree to settle the case. While Respondent maintains that the influenza vaccine
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available online in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). did not cause Petitioner’s injury, the parties filed a stipulation on March 12, 2020. See Stip. at 1– 2 (ECF No. 50).
Based upon my own review of the record, I conclude that the parties’ stipulation (as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.
The stipulation awards:
• A lump sum of $189,072.65, in the form of a check payable to Petitioner; and • An amount sufficient to purchase an annuity contract as described in Paragraph 10 of the parties’ stipulation (as attached hereto).
Stip. at 2. This amount represents compensation for all damages under Section 15(a) of the Act to which Petitioner is entitled.
I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the Court is directed to enter judgment herewith. 3
IT IS SO ORDERED.
/s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review.
2 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 1 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS
) CAMERON SHARP, ) ) Petitioner, ) V. ) ) No. 17-628V SECRETARY OF HEALTH ) Chief Special Master Corcoran AND HUMAN SERVICES, ) ECF ) Respondent. )
STIPULATION
The parties hereby stipulate to the following matters:
1. Cameron Sharp, petitioner, filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (the "Vaccine
Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt
of an influenza ("flu') vaccine, which vaccine is contained in the Vaccine Injury Table (the
"Table"), 42 C.F.R. § 100.3 (a).
2. Petitioner received his flu vaccination on December 17, 2015.
3. The vaccination was administered within the United States.
4. Petitioner alleges that he suffered from chronic inflammatory demyelinating
polyneuropathy ("CIDP") as a result of receiving the flu vaccine, and that he experienced the
residual effects of this injury for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on his behalf as a result of his condition.
6. Respondent denies that the flu vaccine caused petitioner to suffer from CIDP or any Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 2 of 7
other injury or his current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-21(a)(l), the Secretary of Health and Human Services will issue
the following vaccine compensation payments:
a. A lump sum of $189,072.65, which amount represents compensation for first year life care expenses ($5,000.00), pain and suffering ($171,000.00) and past unreimbursable expenses ($13,072.65) in the form of a check payable to petitioner; and
b. An amount sufficient to purchase the annuity contract described in paragraph 10 below, paid to the life insurance company from which the annuity will be purchased (the "Life Insurance Company").
These amounts represent compensation for all damages that would be available under 42 U.S.C. §300aa-15(a).
9. The Life Insurance Company must have a minimum of$250,000,000 capital and
surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company
must have one of the following ratings from two of the following rating organizations:
a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;
b. Moody's Investor Service Claims Paying Rating: Aa3, Aa2, Aal, or Aaa;
c. Standard and Poor's Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or AAA;
d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating: AA-, AA, AA+, or AAA.
10. The Secretary of Health and Human Services agrees to purchase an annuity contract
from the Life Insurance Company for the benefit of petitioner, Cameron Sharp, pursuant to
2 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 3 of 7
Free access — add to your briefcase to read the full text and ask questions with AI
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-628V (not to be published)
************************* CAMERON SHARP, * * * Chief Special Master Corcoran * Petitioner, * Filed: March 25, 2020 * v. * * Decision by Stipulation; Influenza Vaccine; SECRETARY OF HEALTH * Chronic Inflammatory Demyelinating AND HUMAN SERVICES, * Polyneuropathy. * Respondent. * * *************************
Amber D. Wilson, Maglio Christopher & Toale, P.A., Washington, D.C., for Petitioner.
Camille M. Collett, U.S. Dep’t of Justice, Washington, DC, for Respondent.
DECISION ON STIPULATION 1
On May 11, 2017, Cameron Sharp filed a petition seeking compensation under the National Vaccine Injury Compensation Program. 2 ECF No. 1. Petitioner alleged that he suffered from chronic inflammatory demyelinating polyneuropathy as a result of the influenza vaccine he received on December 7, 2015. Id. at 1. In October 2017, the parties began exploring informal resolution of the case. See Resp’s Status Rep. at 1, filed Oct. 7, 2017 (ECF No. 15). Eventually the parties were able to agree to settle the case. While Respondent maintains that the influenza vaccine
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available online in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). did not cause Petitioner’s injury, the parties filed a stipulation on March 12, 2020. See Stip. at 1– 2 (ECF No. 50).
Based upon my own review of the record, I conclude that the parties’ stipulation (as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.
The stipulation awards:
• A lump sum of $189,072.65, in the form of a check payable to Petitioner; and • An amount sufficient to purchase an annuity contract as described in Paragraph 10 of the parties’ stipulation (as attached hereto).
Stip. at 2. This amount represents compensation for all damages under Section 15(a) of the Act to which Petitioner is entitled.
I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the Court is directed to enter judgment herewith. 3
IT IS SO ORDERED.
/s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review.
2 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 1 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS
) CAMERON SHARP, ) ) Petitioner, ) V. ) ) No. 17-628V SECRETARY OF HEALTH ) Chief Special Master Corcoran AND HUMAN SERVICES, ) ECF ) Respondent. )
STIPULATION
The parties hereby stipulate to the following matters:
1. Cameron Sharp, petitioner, filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (the "Vaccine
Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt
of an influenza ("flu') vaccine, which vaccine is contained in the Vaccine Injury Table (the
"Table"), 42 C.F.R. § 100.3 (a).
2. Petitioner received his flu vaccination on December 17, 2015.
3. The vaccination was administered within the United States.
4. Petitioner alleges that he suffered from chronic inflammatory demyelinating
polyneuropathy ("CIDP") as a result of receiving the flu vaccine, and that he experienced the
residual effects of this injury for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on his behalf as a result of his condition.
6. Respondent denies that the flu vaccine caused petitioner to suffer from CIDP or any Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 2 of 7
other injury or his current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-21(a)(l), the Secretary of Health and Human Services will issue
the following vaccine compensation payments:
a. A lump sum of $189,072.65, which amount represents compensation for first year life care expenses ($5,000.00), pain and suffering ($171,000.00) and past unreimbursable expenses ($13,072.65) in the form of a check payable to petitioner; and
b. An amount sufficient to purchase the annuity contract described in paragraph 10 below, paid to the life insurance company from which the annuity will be purchased (the "Life Insurance Company").
These amounts represent compensation for all damages that would be available under 42 U.S.C. §300aa-15(a).
9. The Life Insurance Company must have a minimum of$250,000,000 capital and
surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company
must have one of the following ratings from two of the following rating organizations:
a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;
b. Moody's Investor Service Claims Paying Rating: Aa3, Aa2, Aal, or Aaa;
c. Standard and Poor's Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or AAA;
d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating: AA-, AA, AA+, or AAA.
10. The Secretary of Health and Human Services agrees to purchase an annuity contract
from the Life Insurance Company for the benefit of petitioner, Cameron Sharp, pursuant to
2 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 3 of 7
which the Life Insurance Company will agree to make payments periodically to petitioner as
follows for all other damages that would be available under 42 U.S.C. §300aa-15(a).
a. For future unreimbursable Insurance Maximum out of Pocket expenses, beginning on the first anniversary of the date of judgment, an annual amount of$5,000.00 to be paid up to the anniversary of the date of judgment in year 2025, increasing at the rate of three percent (3%), compounded annually from the date of judgment.
b. For future unreimbursable Affordable Care Act Maximum out of Pocket expenses, beginning on the anniversary of the date ofj udgment in year 2025, an annual amount of $5,500.00 to be paid up to the anniversary of the date of judgment in year 2064, increasing at the rate of three percent (3%), compounded annually from the date of judgment.
c. For future unreimbursable Medicare Part B Deductible expenses, beginning on the anniversary of the date of judgment in year 2064, an annual amount of $198.00 to be paid for the remainder of petitioner's life, increasing at the rate of three percent (3%), compounded annually from the date ofjudgment.
d. For future unreimbursable Medigap Plan G and Medicare Part D expenses, beginning on the anniversary of the date ofjudgment in year 2064, an annual amount of $2,034.36 to be paid for the remainder of petitioner's life, increasing at the rate of three percent (3%), compounded annually from the date of judgment.
At the sole discretion of the Secretary of Health and Human Services, the periodic payments set ·
forth in paragraph 10 above may be provided to petitioner in monthly, quarterly, annual or other
installments. The "annual amounts" set forth above describe only the total yearly sum to be paid
to petitioner and do not require that the payment be made in one annual installment. Petitioner
will continue to receive the annuity payments from the Life Insurance Company only so long as
he, Cameron Sharp, is alive at the time that a particular payment is due. Written notice shall be
provided to the Secretary of Health and Human Services and the Life Insurance Company within
twenty (20) days of Cameron Sharp's death.
11. The annuity contracts will be owned solely and exclusively by the Secretary of
Health and Human Services and will be purchased as soon as practicable following the entry of a
judgment in confonnity with this Stipulation. The parties stipulate and agree that the Secretary
3 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 4 of 7
of Health and Human Services and the United States of America are not responsible for the
payment of any sums other than the amounts set forth in paragraph 8 herein and the amounts
awarded pursuant to paragraph 12 herein, and that they do not guarantee or insure any of the
future annuity payments. Upon the purchase of the annuity contract, the Secretary of Health and
Human Services and the United States of America are released from any and all obligations with
respect to future annuity payments.
12. As soon as practicable after the entry of judgment on entitlement in this case, and
after petitioner has filed both a proper and timely election to receive compensation pursuant to
42 U.S.C. § 300aa-2l(a)(I ), and an application, the parties will submit to further proceedings
before the special master to award reasonable attorneys' fees and costs incurred in proceeding
upon this petition.
13. Petitioner and his attorney represent that they have identified to respondent all
known sources of payment for items or services for which the Program is not primarily liable
under 42 U.S.C. § 300aa- 15(g), including State compensation programs, insurance policies,
Federal or State health benefits programs (other than Title XIX of the Social Security Act
(42 U.S.C. § 1396 et seq.)), or entities that provide health services on a pre-paid basis.
14. Payments made pursuant to paragraph 8 and any amounts awarded pursuant to
paragraph 12 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i),
subject to the availability of sufficient statutory funds.
15. The parties and their attorneys further agree and stipulate that, except for any award
for attorneys' fees and litigation costs, and past unreimbursable expenses, the money provided
pursuant to this Stipulation either immediately or as part of the annuity contract, will be used
4 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 5 of 7
solely for petitioner's benefit as contemplated by a strict construction of 42 U.S.C. §§ 300aa-
15(a) and (d), and subject to the conditions of 42 U.S.C. §§ 300aa-15(g) and (h).
16. In return for the payments described in paragraphs 8 and 12, petitioner, in his
individual capacity, and on behalf of his heirs, executors, administrato~s, successors or assigns,
does forever irrevocably and unconditionally release, acquit and discharge the United States and
the Secretary of Health and Human Services from any and all actions or causes of action
(including agreements, j udgments, claims, damages, loss of services, expenses and all demands
of whatever kind or nature) that have been brought, could have been brought, or could be timely
brought in the Court of Federal Claims, under the National Vaccine Injury Compensation
Program, 42 U.S.C. § 300 aa-10 -et seq., on account of, or in any way growing out of, any and all
known or unknown, suspected or unsuspected personal injuries to or death of petitioner resulting
from, or alleged to have resulted from, the flu vaccination administered on December 17, 2015,
as alleged by petitioner in a petition for vaccine compensation filed on or about May 11, 2017, in
the United States Court of Federal Claims as petition No. l 7-628V.
17. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
18. If the special master fails to issue a decision in complete conformity with the terms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
decision that is in complete conformity with the terms of this Stipulation, then the parties'
settlement and this Stipulation shall be voidable at the sole discretion of either party.
19. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 12 above. There is absolutely no agreement on the part of the
5 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 6 of 7
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties' respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
20. Petitioner hereby authorizes respondent to disclose documents filed by petitioner in
this case consistent with the Privacy Act and the routine uses described in the National Vaccine
Injury Compensation Program System of Records, No. 09-15-0056.
21. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that the flu vaccine caused petitioner's alleged CIDP or
any other injury or his current condition.
22. All rights and obligations of petitioner hereunder shall apply equally to petitioner's
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION I I I I I I I I I I I I I I
6 Case 1:17-w-00628-UNJ Document 50 Filed 03/12/20 Page 7 of 7
Respectfully submitted,
PETITIO:,e -~wJ1 c ER ATTORNEY OF RECORD FOR AlITHORIZED REPRESENTATIVE PE TIONER: OF THE ATTORNEY GENERAL:
]l-uu,Jl~J.JR D. WILSON, ESQ. GLIO CHRISTOPHER & TOALE, PA 1015 15 Street N.W. Torts Branch, Civil Division Suite 1125 U.S. Department ofJustice Washington, DC 20006 P.O. Box 146 Tel: (888) 952-5242 Benjamin Franklin Station Washington, DC 20044-0146
AUTHORIZED REPRESENTATIVE AITORNEYOFRECORDFOR OF THE SECRETARY OF HEALTH RESPONDENT: AND HUMAN SERVICES: )
~ 1 1 1 .. Cotl.e;tt-P'f ~CL- TAMARA OVERBY CAMILLE M. COLLETT Acting Director, Division of Injury Trial Attorney Compensation Programs Torts Branch Healthcare Systems Bureau Civil Division U.S. Department of Health U.S. Department of Justice and Human Services P.O. Box 146 5600 Fishers Lane Benjamin Franklin Station Parklawn Building, Mail Stop 11 C-26 Washington, DC 20044-0146 Rockville, MD 20857 Tel: (202) 616-4098
Dated: Mvct,, u, 2.ow